The Detoxification report focuses on the key genes and variants involved in regulating Phase I, II and III liver detoxification pathways including those involved in the metabolism of caffeine, alcohol, hormones, neurotransmitters, pesticides and various common pharmaceutical drugs.
PLEASE ENSURE THAT YOU HAVE INCLUDED THE DNA TEST PRODUCT IN THIS ORDER.
This report focuses on the key genes and variants (SNPs) involved in regulating Phase I, II and III detoxification pathways.
personalised, colour coded genotype results
gene function and SNP impact descriptions
clinically relevant SNPs
nutrient and other epigenetic impacts
follow up functional testing options
nutrition and lifestyle recommendations
dynamic links to research evidence
CYP450 family: CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4
Alcohol: ADH1B, ADH1C and ALDH2
Neurotransmitters: MAOA and MAOB
Glucuronidation: UGT1A1 and UGT1A6
Sulphonation: SULT1A1, SULT1A2 and SULT2A1
Glutathione conjugation: GSTM1, GSTP1 and GSTT1
Acetylation: NAT1 and NAT2
Methylation: COMT and TPMT